Case 3: Female with a complaint of vaginal discharge.
Focus on bacterial vaginosis (BV) and trichomonas vaginitis

Goal: To improve health care providers' ability to recognize, diagnose and treat Vaginitis.

Objectives:

1. Describe the initial clinical approach to a female patient with a complaint of vaginal discharge including history and physical examination.
2. Identify the typical signs and symptoms of the common types of infectious vaginitis.
3. Select the appropriate laboratory tests for infectious vaginitis.
4. Describe the diagnostic criteria for bacterial vaginosis (BV) and trichomonas vaginitis.
5. Describe the appropriate treatment for BV and trichomonas vaginitis.
6. Explain the inter-relationships between BV and trichomonas vaginitis and infection with Human Immunodeficiency Virus.
7. Explain how Stage-based Behavioral Counseling can be used for STD/HIV prevention.
8. Explain the recommendations for management of sexual partners of women with BV and/or trichomonas vaginitis.

Development Team:

Clinical content

Clinical content was developed by Patricia Coury-Doniger, MS, FNP of the New York State STD/HIV Prevention Training Center, Rochester and Maureen Scahill, MS, NP of the New York State STD/HIV Prevention Training Center, Rochester, New York.

Risk Reduction content

Content on risk reduction was developed by Patricia Coury-Doniger, MS, FNP of the New York State STD/HIV Prevention Training Center, Rochester and Maureen Scahill, MS, NP of the New York State STD/HIV Prevention Training Center, Rochester, New York.

Partner Management content

Tammy Foskey, MA, Assistant Director of the Texas STD/HIV Prevention Training Center and Sue Anne Payette, MS, Training Director of the New York State STD/HIV Prevention Training Center

Disclosure:

CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.

Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.

Content Expert Reviewers:

• Emilia Koumans, MD, Medical Officer, Division of STD Prevention, National Center for HIV, STD and TB Prevention, CDC
• Jeanne Marrazzo, MD, MPH, Associate Professor of Medicine, University of Washington School of Medicine and Medical Director, Seattle STD/HIV Prevention Training Center
• Sylvie Ratelle, MD, MPH, Medical Director, Division of STD Prevention, Massachusetts Department of Public Health, Medical Director of the STD/HIV Prevention Training Center of New England and Assistant Professor of Family Medicine and Community Health, University of Massachusetts Medical School
• Marianne Scharbo-DeHaan, PhD, CNM, Section Chief, Medical Education and Evaluation, Division of STD Prevention, National Center for HIV, STD and TB Prevention, CDC
• Marguerite Urban, MD, Medical Director, STD/HIV Program, Associate Professor of Medicine, University of Rochester and New York State STD/HIV Prevention Training Center

Project Management:

Seattle STD/HIV Prevention Training Center,
University of Washington

Online Course Design and Programming:

Henry Sobel, President, Huge Media, Berkeley, California

Project Funding:

California STD/HIV Prevention Training Center, California Department of Health Services

New England STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Seattle STD/HIV Prevention Training Center, University of Washington

This project was made possible through funding by the Centers for Disease Control and Prevention.